Literature DB >> 19657737

Regression of B-cell lymphoma of the liver with hepatitis C virus infection after treatment with pegylated interferon-alpha and ribavirin.

Yayoi Oda1, Tadayuki Kou, Masaki Watanabe, Yojiro Sakuma, Nori Taguchi, Yoko Kato, Yasushi Kudo, Atsushi Yamauchi, Yasushi Sugiura, Shinya Ohashi, Masanori Asada, Toyokazu Fukunaga, Kiyotaka Kawaguchi, Hiroaki Ito, Takefumi Nakamura, Shujiro Yazumi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19657737     DOI： 10.1007/s10620-009-0902-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  13 in total

1.  Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection.

Authors:  S De Vita; C Sacco; D Sansonno; A Gloghini; F Dammacco; M Crovatto; G Santini; R Dolcetti; M Boiocchi; A Carbone; V Zagonel
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

2.  Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma.

Authors:  E Zuckerman; T Zuckerman; A M Levine; D Douer; K Gutekunst; M Mizokami; D G Qian; M Velankar; B N Nathwani; T L Fong
Journal:  Ann Intern Med       Date:  1997-09-15       Impact factor: 25.391

Review 3.  Hepatitis C virus and lymphoma.

Authors:  D S Viswanatha; A Dogan
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

4.  Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience.

Authors:  Daniele Vallisa; Patrizia Bernuzzi; Luca Arcaini; Stefano Sacchi; Vittorio Callea; Roberto Marasca; Antonio Lazzaro; Elena Trabacchi; Elisa Anselmi; Anna Lisa Arcari; Carlo Moroni; Raffaella Bertè; Mario Lazzarino; Luigi Cavanna
Journal:  J Clin Oncol       Date:  2005-01-20       Impact factor: 44.544

Review 5.  Mechanisms of B-cell lymphoma pathogenesis.

Authors:  Ralf Küppers
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

6.  Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH.

Authors:  Alexandra Nieters; Birgit Kallinowski; Paul Brennan; Melanie Ott; Marc Maynadié; Yolanda Benavente; Lenka Foretova; Pier Luigi Cocco; Anthony Staines; Martine Vornanen; Denise Whitby; Paolo Boffetta; Nikolaus Becker; Silvia De Sanjosé
Journal:  Gastroenterology       Date:  2006-09-20       Impact factor: 22.682

7.  Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori.

Authors:  A C Wotherspoon; C Doglioni; T C Diss; L Pan; A Moschini; M de Boni; P G Isaacson
Journal:  Lancet       Date:  1993-09-04       Impact factor: 79.321

Review 8.  Hepatitis C virus (HCV) and lymphomagenesis.

Authors:  Wen-Kai Weng; Shoshana Levy
Journal:  Leuk Lymphoma       Date:  2003-07

9.  Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.

Authors:  Thomas P Giordano; Louise Henderson; Ola Landgren; Elizabeth Y Chiao; Jennifer R Kramer; Hashem El-Serag; Eric A Engels
Journal:  JAMA       Date:  2007-05-09       Impact factor: 56.272

10.  Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis.

Authors:  Javier P Gisbert; Luisa García-Buey; José María Pajares; Ricardo Moreno-Otero
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682
View more
  4 in total

Review 1.  Non-Hodgkin lymphoma and hepatitis C: where we are and what next?

Authors:  Mihály Sulyok; Mihály Makara; Eszter Újhelyi; István Vályi-Nagy
Journal:  Pathol Oncol Res       Date:  2014-10-02       Impact factor: 3.201

2.  Etiological factors in primary hepatic B-cell lymphoma.

Authors:  Kanta Kikuma; Jiro Watanabe; Yumi Oshiro; Tatsuo Shimogama; Yumi Honda; Seiichi Okamura; Koichi Higaki; Naokuni Uike; Tetsuro Soda; Seiya Momosaki; Tadaaki Yokota; Satoshi Toyoshima; Morishige Takeshita
Journal:  Virchows Arch       Date:  2012-03-07       Impact factor: 4.064

Review 3.  Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy.

Authors:  Luca Arcaini; Michele Merli; Stefano Volpetti; Sara Rattotti; Manuel Gotti; Francesco Zaja
Journal:  Clin Dev Immunol       Date:  2012-08-26

Review 4.  Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.

Authors:  Michele Merli; Giuseppe Carli; Luca Arcaini; Carlo Visco
Journal:  World J Gastroenterol       Date:  2016-10-14       Impact factor: 5.742
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.